Dr. Andrew Gallimore is a computational neurobiologist, pharmacologist, chemist, and writer who has been interested in the neural basis of psychedelic drug action for many years and is the author of a number of articles and research papers on the powerful psychedelic drug, N,N-dimethyltryptamine (DMT) and its effects on the brain and consciousness.

In 2015, he collaborated with DMT pioneer Dr. Rick Strassman, author of DMT: The Spirit Molecule, to develop a pharmacokinetic model of DMT as the basis of a target-controlled intravenous infusion protocol for extended journeys in the bizarre worlds to which DMT gates access.

His current interests focus on DMT and other psychedelic molecules as tool for gating access to otherwise inaccessible subjective worlds, their neuroscientific underpinning, and their possible ontological and metaphysical implications. He currently lives and works in Tokyo where he joined us to record today’s show.

Dr. Gallimore is paving the way with DMTx, at www.noonautics.com, with a team of scientists, researchers, and academics using machine learning and psychedelics. We discuss the common experience reported of users that feel transported to another dimension of hyper advanced technology and beings they can communicate with that are not of this world. This may be a window into accessing high-dimensional intelligence.

The research shows that this could be used in many ways, which include the treatment of coming to terms with mortality, PTSD, and reversing suicidal thoughts.

To follow Dr. Gallimore’s groundbreaking work go to x.com/alientinsect